Elevated BUB1 expression correlates with aggressive phenotypes and unfavorable prognosis in various cancers, such as pancreatic ductal adenocarcinoma, breast cancer, glioblastoma, and papillary thyroid cancer [61–64]. Here, BUB1 is linked to breast cancer.